Attempted Suicide, Dexamethasone, and COVID-19: Clinical Case on COVID-19 Treatments and the Implications for Mental Health

Benedicto Crespo-Facorro, MD, PhD^a,b,c; Beatriz O. Plasencia-García, MD^a,b; Elena García-Ligero, MD^a; Irene E. Menéndez, MD^a; Francisco Gotor, MD^a,b; Yolanda González-Fuentes, RN^a

Prim Care Companion CNS Disord 2022;24(5):22cr03296

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (13)

WHO. Coronavirus Disease (COVID-19) - events as they happen. World Health Organization website. Accessed June 27, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
Horby P, Lim WS, Emberson JR, et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693–704. PubMed CrossRef
Cheng B, Ma J, Yang Y, et al. Systemic corticosteroid administration in coronavirus disease 2019 outcomes: an umbrella meta-analysis incorporating both mild and pulmonary fibrosis-manifested severe disease. Front Pharmacol. 2021;12:670170. PubMed CrossRef
Sánchez García MD, Pecino Esquerdo B, Pérez Martínez E. Manía inducida por el tratamiento con corticoesteroides: revisión a partir de un caso clínico. Rev Asoc Esp Neuropsiq. 2015;35(126):323–340. CrossRef
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–1367. PubMed CrossRef
Judd LL, Schettler PJ, Brown ES, et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry. 2014;171(10):1045–1051. PubMed CrossRef
World Health Organization. Suicide Worldwide in 2019: Global Health Estimates. World Health Organization website. Accessed October 24, 2021. https://apps.who.int/iris/handle/10665/341728
Laugesen K, Farkas DK, Vestergaard M, et al. Glucocorticoid use and risk of suicide: a Danish population-based case-control study. World Psychiatry. 2021;20(1):142–143. PubMed CrossRef
Zhang W, Egashira N, Masuda S. Recent topics on the mechanisms of immunosuppressive therapy-related neurotoxicities. Int J Mol Sci. 2019;20(13):3210. PubMed CrossRef
Popoli M. Agomelatine: innovative pharmacological approach in depression. CNS Drugs. 2009;23(suppl 2):27–34. PubMed CrossRef
Rogers JP, Watson CJ, Badenoch J, et al. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry. 2021;92(9):932–941. CrossRef
Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. PubMed CrossRef
Jenkins CA, Bruera E. Difficulties in diagnosing neuropsychiatric complications of corticosteroids in advanced cancer patients: two case reports. J Pain Symptom Manage. 2000;19(4):309–317. PubMed CrossRef